In particular, we explored the effects of PF on improving fatty liver and IR in NAFLD rats based on its effects on the lipid metabolism-associated regulators and insulin-associated IRS/Akt/GSK3β pathway. Here, GSK3B is linked to metabolic dysfunction-associated steatotic liver disease.